广发纳斯达克生物科技人民币(001092)

动态评分: 5.28分

投资组合

报告日期 名称 比例
2020-12-31 FibroGen Inc 0.29%
2020-12-31 内克塔治疗 0.29%
2020-12-31 Insmed Inc 0.28%
2020-12-31 Deciphera Pharmaceuticals Inc 0.28%
2020-12-31 阿尔凯默斯 0.27%
2020-12-31 Allogene Therapeutics Inc 0.27%
2020-12-31 Intellia Therapeutics Inc 0.27%
2020-12-31 Rocket Pharmaceuticals Inc 0.26%
2020-12-31 Axsome Therapeutics Inc 0.26%
2020-12-31 Agios Pharmaceuticals Inc 0.26%
2020-12-31 Karuna Therapeutics Inc 0.24%
2020-12-31 OPKO健康 0.23%
2020-12-31 全球血液疗法 0.23%
2020-12-31 蓝鸟生物 0.23%
2020-12-31 Veracyte Inc 0.23%
2020-12-31 Pacira BioSciences Inc 0.22%
2020-12-31 Xencor Inc 0.21%
2020-12-31 NanoString Technologies Inc 0.21%
2020-12-31 Intra-Cellular Therapies Inc 0.2%
2020-12-31 基立福 0.19%

投资模拟

公告&资料